.jpg){kind=logo}
A HISTORIC INTERNATIONAL SCIENTIFIC MEETING
Global Breast Implant Illness Symposium
Advancing Science • Informing Practice • Improving Lives
Bringing together international physicians, surgeons, scientists, and researchers to advance evidence, multidisciplinary collaboration, and the future of patient care.
Registration Information:
To provide a welcoming and engaging experience for all participants, in-person attendance at De Nieuwe Meer is limited to 55 attendees.
Virtual participation is also available, with 50 complimentary online registrations reserved for individuals affected by Breast Implant Illness (BII).
Online registration for healthcare professionals is unlimited. All registrations will be confirmed in the order received, subject to availability.
We look forward to bringing together patients, healthcare professionals, and researchers to advance understanding and awareness of Breast Implant Illness.
LOCATION
HOST + VENUE
DATE
ATTENDANCE
22 January 2027
Amsterdam, Netherlands
Amsterdam UMC,
VUmc - De Nieuwe Meer
ABOUT THE SYMPOSIUM
Building the Scientific Framework
for an Evolving Field
“Advancing BII requires more than recognition. It requires defining the clinical presentation, investigating the biology, and translating discovery into better care. ”
The First International Symposium on Breast Implant Illness brings international multidisciplinary expertise together to advance the science of BII. The program spans clinical presentation and recognition, emerging biological mechanisms, individual susceptibility, diagnostic evaluation, surgical outcomes and recovery, while identifying priorities for future research and patient care.
International
Multi-
disciplinary
Future-
focused
Perspectives and expertise from across the global and clinical community.
Expertise spanning clinical medicine, surgery, immunology, pathology, imaging, and research.
Emerging science, clinical questions, and priorities for future research and care.
CLINICAL EDUCATION
Advancing the Science and Clinical Understanding of
Breast Implant Illness
The First International Symposium on Breast Implant Illness brings together international clinicians, scientists, and researchers to critically examine emerging evidence surrounding systemic symptoms associated with breast implants. Discussions will explore potential biological mechanisms, clinical findings, diagnostic challenges, and opportunities to advance multidisciplinary research and patient care.
Examine the spectrum of systemic manifestations reported by patients with breast implants, including multisystem symptom patterns, clinical characteristics, and challenges in differential diagnosis.
Clinical Presentations and Symptom Patterns
Immunological and
Biological Mechanisms
Explore current and emerging research investigating immune responses, inflammatory pathways, host–implant interactions, and other potential biological mechanisms associated with systemic symptoms.
Clinical Evidence and
Patient Outcomes
Evaluate published clinical research, observational findings, implant-related complications, and patient outcomes, including symptom trajectories following explantation and important limitations in the existing evidence.
Multidisciplinary
Research and Clinical Perspectives
Integrate perspectives from internal medicine, rheumatology, immunology, plastic surgery, radiology, and related specialties to identify knowledge gaps, research priorities, and opportunities for collaborative investigation.
Scientific and Clinical Priorities
Critically evaluate the strength and limitations of current evidence.
Examine proposed pathophysiological mechanisms and clinical observations.
Explore diagnostic challenges and approaches to patient evaluation.
Identify priorities for future research and multidisciplinary collaboration.
SCIENTIFIC DIRECTION
Clinical Insight. Scientific Discovery. Future Direction.
The scientific program spans the evolving landscape of BII from a clinical presentation and patient outcomes to biological mechanisms, individual susceptibility, diagnosis, treatment and recovery-while advancing priorities for future multidisciplinary research and patient care.
01
Clinical Characterization
Clinical presentation, symptom characterization, recognition, diagnosis, treatment, surgical outcomes, and recovery.
02
Biological Mechanisms
Immune response, biomaterials, inflammation, pathology, migration, biofilm, host response, and individual susceptibility.
Emerging research, multidisciplinary collaboration, long-term outcomes, and priorities for the next generation of BII investigation and patient care.
Future Directions
03
Moderator
Presentors
Breast Implant Illness in 2027: What Does the Evidence Actually Show
Explantation, Capsulectomy and Recovery: Evidence from Long Term Clinical Follow-Up
The Hidden Biology of Silicone Gel Bleed: Lessons from Imaging and Pathology
The Biology Behind the Symptoms: Emerging Mechanisms of Implant-Associated Immune Dysregulation
Breast Implant Illness: Where We Have Been, What We Have Learned, and Where We Need to Go
Panelists
PROGRAM
A Full Day of Scientific
Exchange
Expected Itinerary. Subject to Change.
Moderators: Prof. Prabath Nanayakkara and Danielle Valoras
Panelists: Prof. Jan Willem Cohen Tervaert, Dr. Frank Niessen, and Dr. Arthur Brawer
All times are listed in Amsterdam local time (CET).
2:00-2:30 PM
Dr. Siham Azahaf
Breast Implant Illness in 2027: What Does the Evidence Actually Show
2:30-3:00 PM
Dr. Lu-Jean Feng
Explantation, Capsulectomy and Recovery: Evidence from Long Term Clinical Follow-Up
3:00-3:30 PM
Dr. Eduardo Fleury
The Hidden Biology of Silicone Gel Bleed: Lessons from Imaging and Pathology
3:30-4:00 PM
Break
Dr. Mithun Sinha
4:00-4:30 PM
The Biology Behind the Symptoms: Emerging Mechanisms of Implant-Associated Immune Dysregulation
4:30-5:00 PM
Dr. Arthur Brawer
Breast Implant Illness: Where We Have Been, What We Have Learned, and Where We Need to Go
5:00-6:00 PM
Panel Discussion:
From Evidence to Action: Defining the Future of BII Research and Clinical Care
WHO SHOULD ATTEND
This is an Essential Gathering for Diverse Medical Professionals and Experts Across Disciplines
The Symposium welcomes an international audience committed to expanding scientific understanding and improving clinical practice.
Physcians
Surgeons
Scientists
Researchers
Health Professionals
Healthcare Educators
AMSTERDAM 22 JANUARY 2027
Join us at Amsterdam University Medical Center
In-person participation is warmly welcomed. A live virtual attendance option broadens access for members of the international scientific and healthcare community.
VENUE ADDRESS
Amsterdam UMC,
VUmc - De Nieuwe Meer
De Boelelaan 1117
1081 HV AMSTERDAM
Registration Information:
To provide a welcoming and engaging experience for all participants, in-person attendance at De Nieuwe Meer is limited to 55 attendees.
Virtual participation is also available, with 50 complimentary online registrations reserved for individuals affected by Breast Implant Illness (BII).
Online registration for healthcare professionals is unlimited. All registrations will be confirmed in the order received, subject to availability.
We look forward to bringing together patients, healthcare professionals, and researchers to advance understanding and awareness of Breast Implant Illness.
BE PART OF THE MILESTONE
Register for the Global Breast Implant Illness Symposium
Join international colleagues for a day dedicated to scientific evidence, multidisciplinary collaboration, physician education, and the future of clinical investigation.
In-Person
€200 Euros
Virtual
€150 Euros
* 50 complimentary online registrations reserved for individuals affected by Breast Implant Illness (BII).
